Beneficial effects of soy phytoestrogen intake in postmenopausal women with type 2 diabetes

Diabetes Care

Volumn 25, Issue 10, 2002, Pages 1709-1714

  Jayagopal, Vijay ^a,b   Albertazzi, Paula ^a   Kilpatrick, Eric S ^b   Howarth, Elaine M ^a   Jennings, Paul E ^a,c   Hepburn, David A ^a   Atkin, Stephen L ^a  

^a UNIVERSITY OF HULL   (United Kingdom)

^b HULL ROYAL INFIRMARY   (United Kingdom)

^c YORK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; CELLULOSE; CREATININE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ISOFLAVONE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOESTROGEN; PLACEBO; PRASTERONE SULFATE; SOYBEAN PROTEIN; TRIACYLGLYCEROL; ESTROGEN; GLYCOSYLATED HEMOGLOBIN; HORMONE; ISOFLAVONE DERIVATIVE; LIPID; PLANT MEDICINAL PRODUCT;

ARTICLE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; FREE THYROXINE INDEX; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; METABOLISM; PATIENT COMPLIANCE; PATIENT SELECTION; PHYTOTHERAPY; SOYBEAN;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; CARDIOVASCULAR DISEASES; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ESTROGENS, NON-STEROIDAL; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HORMONES; HUMANS; ISOFLAVONES; LIPIDS; PATIENT COMPLIANCE; PATIENT SELECTION; PHYTOESTROGENS; PHYTOTHERAPY; PLACEBOS; PLANT PREPARATIONS; POSTMENOPAUSE; SOYBEANS;

EID: 0036782541     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.10.1709     Document Type: Article

References (32)

1. Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E: Cardiovascular disease iri women: a statement for Healthcare professionals from the American Heart Association Writing Group. Circulation 96:2468-2482, 1997
2. Eastman RC, Keen H: The impact of cardiovascular disease on people with diabetes: the potential for prevention. Lancet 350 (Suppl. 1):SI29-SI32, 1997
3. Greenland P, Reicher-Reiss H, Goldbourt U, Behar S: In-hospital and 1-year mortality in 1,524 women after myocardial infarction: comparison with 4,315 men. Circulation 83:484-491, 1991
4. Sowers JR: Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 158:617-621, 1998
5. Stoney RM, O'Dea K, Herbert KE, Dragicevic G, Giles GG, Cumpston GN, Best JD: Insulin resistance as a major determinant of increased coronary heart disease risk in postmenopausal women with type 2 diabetes mellitus. Diabet Med 18:476-482, 2001
6. Fujimoto WY, Leonetti DL, Kinyouh JL, Newell-Morris L, Shuman WP, Stolov WC, Wahl PW: Prevalence of diabetes mellitus and impaired glucose tolerance among second-generation Japanese-American men. Diabetes 36:721-729, 1987
7. Fujimoto WY, Leonetti DL, Bergstrom RW, Kinyoun JL, Stolov WC, Wahl PW: Glucose intolerance and diabetic complications among Japanese-American women. Diabetes Res Clin Pract 13:119-129, 1991
8. Fujimoto WY, Akanuma Y, Kanazawa Y, Mashiko S, Leonetti D, Wahl P: Plasma insulin levels in Japanese and Japanese-American men with type 2 diabetes may be related to the occurrence of cardiovascular disease. Diabetes Res Clin Pract 6:121-127, 1989
9. Fujimoto WY: The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 108 (Suppl. 6a):9S-14S, 2000
10. Anderson JW, Smith BM, Washnock CS: Cardiovascular and renal benefits of dry bean and soybean intake. Am J Clin Nutr 70:464S-474S, 1999
11. Vedavanam K, Srijayanta S, O'Reilly J, Raman A, Wiseman H: Antioxidant action and potential antidiabetic properties of an isoflavonoid-containing soyabean phytochemical extract (SPE). Phytother Res 13:601-608, 1999
12. Lee DS, Lee SH: Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. FEBS Lett 501:84-86, 2001
13. Sorenson RL, Brelje TC, Roth C: Effect of tyrosine kinase inhibitors on islets of Langerhans: evidence for tyrosine kinases in the regulation of insulin secretion. Endocrinology 134:1975-1978, 1994
14. Wagner JD, Cefalu WT, Anthony MS, Litwak KN, Zhang L, Clarkson TB: Dietary soy protein and estrogen replacement therapy improve cardiovascular risk factors and decrease aortic cholesteryl ester content in ovariectomized cynomolgus monkeys. Metabolism 46:698-705, 1997
15. Duncan AM, Underhill KE, Xu X, Lavalleur J, Phipps WR, Kurzer MS: Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab 84:3479-3484, 1999
16. Goodman-Gruen D, Kritz-Silverstein D: Usual dietary isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J Nutr 131:1202-1206, 2001
17. Hermansen K, Sondergaard M, Hoie L, Carstensen M, Brock B: Beneficial effects of a soy-based dietary supplement on lipid levels and cardiovascular risk markers in type 2 diabetic subjects. Diabetes Care 24:228-233, 2001
18. Tsai AC, Vinik AI, Lasichak A, Lo GS: Effects of soy polysaccharide on postprandial plasma glucose, insulin, glucagon, pancreatic polypeptide, somatostatin, and triglyceride in obese diabetic patients. Am J Clin Nutr 45:596-601, 1987
19. Mahalko JR, Sandstead HH, Johnson LK, Inman LF, Milne DB, Warner RC, Haunz EA: Effect of consuming fiber from corn bran, soy hulls, or apple powder on glucose tolerance and plasma lipids in type II diabetes. Am J Clin Nutr 39:25-34, 1984
20. Thomas BL, Laine DC, Goetz FC: Glucose and insulin response in diabetic subjects: acute effect of carbohydrate level and the addition of soy polysaccharide in defined-formula diets. Am J Clin Nutr 48:1048-1052, 1988
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419, 1985
22. Anderson JW, Johnstone BM, Cook-Newell ME: Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333:276-282, 1995
23. Friedenwald J, Ruhrah J: The use of the soy bean as a food in diabetes. Am J Med Sci 140:793-803, 1910
24. Jonas JC, Plant TD, Gilon P, Detimary P, Nenquin M, Henquin JC: Multiple effects and stimulation of insulin secretion by the tyrosine kinase inhibitor genistein in normal mouse islets. Br J Pharmacol 114:872-880, 1995
25. Abler A, Smith JA, Randazzo PA, Rothenberg PL, Jarett L: Genistein differentially inhibits postreceptor effects of insulin in rat adipocytes without inhibiting the insulin receptor kinase. J Biol Chem 267:3946-3951, 1992
26. Kipnes MS, Krosnick A, Rendell MS, Egan JW, Mathisen AL, Schneider RL: Pioglitazone hydrochloride in combination with sulfonylurea therapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, placebo-controlled study. Am J Med 111:10-17, 2001
27. Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP: Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 86:3053-3060, 2001
28. Honore EK, Williams JK, Anthony MS, Clarkson TB: Soy isoflavones enhance coronary vascular reactivity in atherosclerotic female macaques. Fertil Steril 67:148-154, 1997
29. Wagner JD, Zhang L, Greaves KA, Shadoan MK, Schwenke DC: Soy protein reduces the arterial low-density lipoprotein (LDL) concentration and delivery of LDL cholesterol to the arteries of diabetic and nondiabetic male cynomolgus monkeys. Metabolism 49:1188-1196, 2000
30. Duncan AM, Merz BE, Xu X, Nagel TC, Phipps WR, Kurzer MS: Soy isoflavones exert modest hormonal effects in premenopausal women. J Clin Endocrinol Metab 84:192-197, 1999
31. Forsythe WA 3rd: Soy protein, thyroid regulation and cholesterol metabolism. J Nutr 125:619S-623S, 1995
32. Barnes S, Peterson TG, Coward L: Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 22:181-187, 1995